Lexicon Pharmaceuticals, Inc.

LXRXNASDAQUSD
1.91 USD
0.01 (0.53%)AT CLOSE (11:59 AM EDT)
1.90
0.02 (0.79%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
1.90
0.02 (0.79%)
🔴Market: CLOSED
Open?$1.90
High?$1.94
Low?$1.87
Prev. Close?$1.90
Volume?1.8M
Avg. Volume?2.8M
VWAP?$1.90
Rel. Volume?0.64x
Bid / Ask
Bid?$1.89 × 400
Ask?$1.90 × 1.9K
Spread?$0.01
Midpoint?$1.90
Valuation & Ratios
Market Cap?848.4M
Shares Out?444.2M
Float?159.0M
Float %?43.7%
P/E Ratio?N/A
P/B Ratio?4.18
EPS?-$0.06
Dividend?0.00%
Ex-Dividend?N/A

Lexicon Pharmaceuticals, Inc. (LXRX) trades at $1.91 per share. Technicals currently rate "Neutral" while our fundamental analysis reads "Neutral". Notable factors include a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
Employees
81
Market Cap
848.4M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2000-04-07
Address
2445 TECHNOLOGY FOREST BLVD.
THE WOODLANDS, TX 77381
Phone: (281) 863-3000
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)? Neutral(0/3)
Medium-Term (Wave)? Neutral(0/3)
Short-Term (Ripple)? Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
0
Momentum?
57
Short Sent.?
40
Piotroski F-Score?5/9Mixed
Altman Z-Score?-2.07Distress
Confidence?59%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?16.44%High
Short Interest?26.1M
Days to Cover?6.2
Free Float159.0M
Avg Daily Volume4.2M
Settlement Date2026-05-15
Financial Health
Current Ratio?18.79Strong
Quick Ratio?18.77Strong
Cash Ratio?3.85Strong
Debt/Equity?0.24Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A
P/B?
Peers
100
S&P
43
4.18FAIR
P/S?
Peers
100
S&P
3
12.21HIGH
P/FCF?
N/A
EV/EBITDA?
S&P
97
-33.8CHEAP
EV/Sales?
Peers
100
S&P
7
12.38HIGH
Returns & Efficiency
ROE?
S&P
9
-12.9%WEAK
ROA?
S&P
3
-9.7%WEAK
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$860.0M
Fundamentals ratios updated end of day